A dynamic, modern business providing quality medicines in the most cost effective and efficient manner
Read more >
Proud to partner with the NHS and exceptional businesses in the UK and around the world
Read more >
Explore our expanding portfolio of products across a broad range of therapeutic areas
Read more >
A collection of ambassador products that demonstrate our ethos – providing quality medicines tailored to patients’ and providers’ needs
Read more >
|
Strength |
75mcg/20mcg |
75mcg/30mcg | ||
|
Form |
Tablets |
Tablets | ||
|
Pack Size |
63 |
63 | ||
|
SmPC |
|
|
||
|
Patient Leaflet |
|
|
||
|
Risk Materials |
|
|
||
|
Letters to HCPs |
|
|
|
Strength |
Form |
Pack Size |
|
75mcg/20mcg |
Tablets |
63 |
| 75mcg/30mcg | Tablets | 63 |
|
SmPC |
|
|
|
Patient Leaflet |
|
|
|
Risk Materials |
|
|
|
Letters to HCPs |
|
|
Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.
